click below
click below
Normal Size Small Size show me how
PC
Term | Definition |
---|---|
Draw a smooth muscle cell demonstrating 3 or 4 mechanism involved with increasing intracellular levels of cAMP | look in book |
Describe how Methemoglobin is formed | the ferrous ion is oxidized to the ferric state |
How does methemoglobin adversely affect tissue oxygenation | Methemoglobin has 5 ion bonds and is missing the bond that oxygen attaches to making it unable to deliver oxygen to the tissues |
Discuss how cooperativity enhances the binding of oxygen to hemoglobin at the lungs and how it facilitates the release of oxygen to the cells at the tissues | When oxygen attaches to the first site it increases the affinity for the second site and so on, this is also true for oxygen unloadiong |
List 4 other factors that influence oxygen-hemoglobin affinity | PaCO2, temperature, hydrogen ions and 2,3 DPG |
What is the lifespan of an RBC | 120days |
State the 2 cyclic nucleotides that interact within bronchial smooth muscle cells determining the net physiologic effect of bronchial smooth muscle | cAMP and cGMP |
Explain how (1) beta-2 stimulation, (2) phosphodiesterase inhibition, and (3) cholinergic blockade influence the biochemical events within bronchial smooth muscle and the ultimate physiologic response (explain separately) | 1) Beta 2 stimulation activates adenyl cyclase and increases cAMP 2) PDE blocks the antigen antibody response resulting in anti-inflammatory and bronchodilation 3)Chlorogenic prevents the mast cell from degranulation and from releasing its mediators |
List 5 vasoactive substances that are released during mast cell degranulation | Histamine, prostaglandins, serotonin, bradykinin and ECF-A |
Describe the rationale for using the following medications for the treatment of bronchospasm: (1) aminophylline, (2) bitolterol, (3) albuterol, (4) Montelukast, and (5) ipotropium bromide. (Describe each separately) | (1) Blocks PDE (2) stimulates the beta-2 receptor (3) stimulates the beta-2 receptor (4) leukotriene modifiers (5) used for cholinergic blockade |